Status:
COMPLETED
Engineering Evaluation of an Eye Movement Monitor Device
Lead Sponsor:
C. Light Technologies, Inc.
Conditions:
Healthy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the engineering evaluation is to verify and validate the design of an eye movement monitor device, the Retitrack, for recording, viewing, measuring, and analyzing temporal characteris...
Detailed Description
This non-significant risk device evaluation involves obtaining retinal images and eye movement measurements with the Retitrack device for purposes of design verification and validation testing. These ...
Eligibility Criteria
Inclusion
- History of good health
- Willing to participate in testing over 1 to 2 days with rest periods
- Willing to participate in device testing involving viewing visual targets, moving eyes as directed, and holding head steady
- Willing to have retinal images recorded for eye movement measurements
Exclusion
- Refractive correction with glasses or contact lenses of more than 12 diopters of myopia or 4 diopters of hyperopia in either eye
- Active eye disease in either eye
- History of ocular surgery or ocular trauma in either eye within the past three months
- Ocular conditions in either eye that could interfere with obtaining a clear retinal image
- Ocular conditions in either eye that could affect the ability to view a stimulus or limit eye movement
- Neurological conditions that could affect eye movements
Key Trial Info
Start Date :
February 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 10 2023
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT05222022
Start Date
February 18 2022
End Date
October 10 2023
Last Update
February 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Blur Product Development
Cary, North Carolina, United States, 27513